Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
5.0
25.84%
60%
—
-7.21%
60%
—
5 Years
Score5.0
Net Growth25.84%
Net Trend60%
Net Income Consistency—
Rev Growth-7.21%
Rev Trend60%
Revenue Consistency—
Cytosorbents Crp fundamental performance
Between 2020 and 2025, revenue declined from $ 39M to $ 37M and net income went from -$ 7M to -$ 8M. Revenue increased in 3 of those 5 years; net income in 3.
Across Cytosorbents Crp's full reported history, from 2013 to 2025, revenue grew from $ 821.79K to $ 37M and net income went from -$ 4M to -$ 8M. Revenue increased in 85% of the years measured; net income in 46%.
Cytosorbents Crp currently holds a 5-year HDB Score of 5.0 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 0.37 | — |
1 Year2025-08-12 | $ 1.06 | -65.09% |
5 Years2021-08-12 | $ 8.00 | -95.38% |
10 Years2016-08-12 | $ 4.72 | -92.16% |
20 Years2006-08-11 | $ 90.00 | -99.59% |
All Time2013-11-07 | $ 3.02 | -87.77% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | 20 Years2006-08-11 | All Time2013-11-07 |
|---|---|---|---|---|---|---|
| Price | $ 0.37 | $ 1.06 | $ 8.00 | $ 4.72 | $ 90.00 | $ 3.02 |
| Return | — | -65.09% | -95.38% | -92.16% | -99.59% | -87.77% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 37M | -$ 18M | $ 4M |
| 2025 | $ 37M | -$ 8M | $ 6M |
| 2024 | $ 35M | -$ 20M | $ 3M |
| 2023 | $ 31M | -$ 29M | $ 14M |
| 2022 | $ 34M | -$ 32M | $ 22M |
| 2021 | $ 40M | -$ 24M | $ 52M |
| 2020 | $ 39M | -$ 7M | $ 71M |
| 2019 | $ 22M | -$ 19M | $ 12M |
| 2018 | $ 20M | -$ 17M | $ 22M |
| 2017 | $ 13M | -$ 8M | $ 17M |
| 2016 | $ 8M | -$ 11M | $ 5M |
| 2015 | $ 4M | -$ 8M | $ 7M |
| 2014 | $ 3M | -$ 9M | $ 5M |
| IPO2013 | $ 821.79K | -$ 4M | $ 2M |
Explore beyond CTSO
You're looking at Cytosorbents Crp. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
